Stereotactic radiotherapy for prostate cancer: A review and future directions.

about

Stereotactic radiotherapy for prostate cancer: A review and future directions.

Item

http://www.wikidata.org/entity/Q42702939

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@en

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@nl

type

Item

label

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@en

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@nl

prefLabel

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@en

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@nl

P1476

Stereotactic radiotherapy for prostate cancer: A review and future directions.

@en

P2093

Ami K Patel-Yadav

http://www.w3.org/2001/XMLSchema#string

Charlotte Rivers

http://www.w3.org/2001/XMLSchema#string

Yusef A Syed

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Stereotactic body radiotherapy for organ-confined prostate cancer.

Clinical characteristics and management of late urinary symptom flare following stereotactic body radiation therapy for prostate cancer

Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomes.

Randomized trial comparing conventional-dose with high-dose conformal radiation therapy in early-stage adenocarcinoma of the prostate: long-term results from proton radiation oncology group/american college of radiology 95-09

Patient-reported urinary incontinence following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer.

Quality of Life and Toxicity after SBRT for Organ-Confined Prostate Cancer, a 7-Year Study.

A Phase II Trial of Stereotactic Ablative Body Radiotherapy for Low-Risk Prostate Cancer Using a Non-Robotic Linear Accelerator and Real-Time Target Tracking: Report of Toxicity, Quality of Life, and Disease Control Outcomes with 5-Year Minimum Foll

A single-center study of 100 consecutive patients with localized prostate cancer treated with stereotactic body radiotherapy.

P304

389-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5306/WJCO.V8.I5.389

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Anurag K Singh

P577

2017-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29067275

http://www.w3.org/2001/XMLSchema#string

P932

5638714

http://www.w3.org/2001/XMLSchema#string